The US Food and Drug Administration (FDA) has started recalling a batc...
"Apart from increased productivity to produce more from less input inc...
While brainstorming ideas for his venture, he saw the need for high qu...
With the two-day BioBusiness Asia conference (BBA) leading the way, Ta...
Despite being home to one sixth of the world's population and carrying...
The Intellectual Property and Science business of Thomson Reuters, the...
New Page 1 The Catalyst Advanced Enzyme Technologies pr...
Highlighting the government's plans to eliminate Tuberculosis (TB) fro...
These diseases kill 8.5 million people annually in WHO's South-East As...
The union health minister, Dr Harsh Vardhan has written to Ms Mamata B...
The drug is sold under the name Vfend in the US. The victory comes in ...
ICON has completed the acquisition of MediMedia Pharma Solutions. The ...
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reporte...
Vyome is involved in the development of next generation antibiotics an...
"Irony is that we don't have an effective system. A robust functional ...
Led by the Hon Andrew Robb AO MP, Australia's Minister for Trade and I...
Bangalore: Venus remedies, one of the first companies to have a dedica...
It first ventured to India in 2008, and has eight locations on four co...